U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948838) titled 'Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment' on April 15.
Brief Summary: High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled ...